Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aatke van der Maas

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|February 4, 2014
Measuring flares in rheumatoid arthritis. (Why) do we need validated criteria?Aatke van der Maas, Alfons A den Broeder
Annals of the Rheumatic Diseases|October 1, 2013
Biologic discontinuation studies: a systematic review of methods; comment on the article by Yoshida et alAatke van der Maas, Noortje van Herwaarden, Alfons A den Broeder
Annals of the Rheumatic Diseases|April 16, 2013
Antidrug antibodies to tumour necrosis factor specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective; comment on the article by Vincent et alAlfons A den Broeder, Aatke van der Maas, Bart J F van den Bemt
Rheumatology (Oxford, England)|March 25, 2010
Dose de-escalation strategies and role of therapeutic drug monitoring of biologics in RAAlfons A den Broeder, Aatke van der Maas, Bart J F van den Bemt
The New England Journal of Medicine|June 3, 2026
Polymyalgia RheumaticaNoortje E S E P Kooijman, Alfons A den Broeder, Aatke van der Maas
Trials|April 16, 2022
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trialDiane E Marsman, Thomas E Bolhuis, Nathan den Broeder, et al.
The Lancet. Rheumatology|January 22, 2024
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trialThomas E Bolhuis, Diane E Marsman, Alfons A den Broeder, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Seasonal influence on incidence of polymyalgia rheumatica: winter might be comingDiane E Marsman, Nathan den Broeder, Calin D Popa, et al.
Rheumatology International|January 24, 2021
Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective studyDiane Marsman, Thomas Bolhuis, Nathan den Broeder, et al.
Rheumatology Advances in Practice|August 22, 2019
Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort studyChantal A M Bouman, Lieke Tweehuysen, Dieneke Haverkort, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|February 4, 2014
Measuring flares in rheumatoid arthritis. (Why) do we need validated criteria?Aatke van der Maas, Alfons A den Broeder
Annals of the Rheumatic Diseases|October 1, 2013
Biologic discontinuation studies: a systematic review of methods; comment on the article by Yoshida et alAatke van der Maas, Noortje van Herwaarden, Alfons A den Broeder
Annals of the Rheumatic Diseases|April 16, 2013
Antidrug antibodies to tumour necrosis factor specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective; comment on the article by Vincent et alAlfons A den Broeder, Aatke van der Maas, Bart J F van den Bemt
Rheumatology (Oxford, England)|March 25, 2010
Dose de-escalation strategies and role of therapeutic drug monitoring of biologics in RAAlfons A den Broeder, Aatke van der Maas, Bart J F van den Bemt
The New England Journal of Medicine|June 3, 2026
Polymyalgia RheumaticaNoortje E S E P Kooijman, Alfons A den Broeder, Aatke van der Maas
Trials|April 16, 2022
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trialDiane E Marsman, Thomas E Bolhuis, Nathan den Broeder, et al.
The Lancet. Rheumatology|January 22, 2024
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trialThomas E Bolhuis, Diane E Marsman, Alfons A den Broeder, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Seasonal influence on incidence of polymyalgia rheumatica: winter might be comingDiane E Marsman, Nathan den Broeder, Calin D Popa, et al.
Rheumatology International|January 24, 2021
Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective studyDiane Marsman, Thomas Bolhuis, Nathan den Broeder, et al.
Rheumatology Advances in Practice|August 22, 2019
Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort studyChantal A M Bouman, Lieke Tweehuysen, Dieneke Haverkort, et al.
Pageof 5